(Q28266298)

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

2 December 2022

author name string

A. E. Emery

1

1 reference

Europe PubMed Central

PubMed ID

1822774

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822774

full work available at URL

2 December 2022

language of work or name

English

0 references

publication date

1991

0 references

https://api.elsevier.com/content/article/PII:096089669190039U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

https://api.elsevier.com/content/article/PII:096089669190039U?httpAccept=text/plain

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Formal genetics of muscular dystrophy

2 December 2022

published in

Neuromuscular Disorders

0 references

volume

1

0 references

page(s)

19-29

0 references

issue

1

0 references

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Estimating the ascertainment probability from the number of ascertainments per proband.

2 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

No sex difference in mutations rates of Duchenne muscular dystrophy.

2 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia

2 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Severe autosomal recessive muscular dystrophy in an extended Sudanese kindred.

2 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease

2 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Autosomal recessive muscular dystrophy in Manitoba Hutterites*

2 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Muscular dystrophy in Saskatchewan Hutterites.

2 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Estimate of the proportion of Duchenne muscular dystrophy with autosomal recessive inheritance

2 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes

2 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada)

2 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Patterns of Neurologic Diseases on Guam

2 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

High incidence of spinal muscular atrophy type I (Werdnig - Hoffmann disease) in the Karaite community in Israel

2 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Cluster of acute infantile spinal muscular atrophy (Werdnig-Hoffmann disease) in a limited area of Reunion Island

2 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Familial motor neuron diseases

2 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Survey of Duchenne type and congenital type of muscular dystrophy in Shimane, Japan

2 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

The Ryukyuan muscular atrophy. An obscure heritable neuromuscular disease found in the islands of southern Japan

2 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

X-linked myopathy with excessive autophagy: a new hereditary muscle disease

2 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Incidence of Duchenne muscular dystrophy in New South Wales and Australian Capital Territory

2 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Pseudohypertrophic Muscular Dystrophy of Childhood: An epidemiological survey in Victoria

2 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Genetic counselling in neuromuscular diseases in Western Australia

2 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Prevalence and incidence of muscular dystrophy in Alberta, Canada

2 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy

2 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Progressive muscular dystrophy in Denmark. Natural history, prevalence and incidence.

2 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

The prevalence of some neurological diseases in Iceland

2 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Muscular Dystrophy: The Relative Frequency in the Different Ethnic Groups in Israel

2 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Prospective study of X-linked progressive muscular dystrophy in Campania

2 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Rapid access to the highly oxygenated aspidosperma alkaloids vindoline, vindorosine, and cathovaline

2 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Epidemiology of Duchenne muscular dystrophy in the province of Turin

2 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Duchenne muscular dystrophy. A population study

2 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Population data on benign and severe forms of X-linked muscular dystrophy

2 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan

2 December 2022

61

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Genetic epidemiology of Duchenne muscular dystrophy in Japan: classical segregation analysis

2 December 2022

62

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya

2 December 2022

63

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to "non-Duchenne muscular dystrophy"

2 December 2022

65

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

On the inheritance of muscular dystrophy; with a note on the blood groups, and a note on colour vision and linkage studies

2 December 2022

69

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Some studies of the Duchenne and autosomal recessive types of muscular dystrophy

2 December 2022

70

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Muscular dystrophy in childhood; the genetic aspect; a field study in the Leeds region of clinical types and their inheritance.

2 December 2022

71

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Muscular dystrophy in Northern Ireland. IV. Some additional data

2 December 2022

73

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

The incidence of Duchenne muscular dystrophy in the South East of Scotland

2 December 2022

74

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota

2 December 2022

76

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Gene studies in newborn males with Duchenne muscular dystrophy detected by neonatal screening

2 December 2022

80

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program

2 December 2022

82

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Muscular dystrophy screening

2 December 2022

83

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy

2 December 2022

84

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Feasibility of neonatal screening for Duchenne muscular dystrophy

2 December 2022

85

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Geographic distribution of hereditary myopathies in northeast Italy

2 December 2022

86

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias

2 December 2022

87

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Dystrophia myotonica with special reference to Northern Ireland

2 December 2022

90

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979).

2 December 2022

91

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Genetic epidemiology of myotonic dystrophy

2 December 2022

92

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

The gene frequency of acute Werdnig-Hoffmann disease (SMA type 1). A total population survey in North-East England

2 December 2022

99

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy

2 December 2022

102

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Charcot-Marie-Tooth disease in northern Finland

2 December 2022

103

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Prevalence and occurrence of some rare neurological diseases in Iceland

2 December 2022

105

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Genetic epidemiology of hereditary motor sensory neuropathies (type I)

2 December 2022

106

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Genetic and clinical aspects of Charcot-Marie-Tooth's disease

2 December 2022

107

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Prevalence of hereditary motor and sensory neuropathy in Cantabria

2 December 2022

108

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

Hereditary motor and sensory neuropathies in Swedish children. I. Prevalence and distribution by disability groups

2 December 2022

109

1 reference

https://api.crossref.org/works/10.1016/0960-8966(91)90039-U

2 December 2022

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

977862

977862

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference